Ctxr analysis
WebApr 13, 2024 · CTXR Stock Price Performance Analysis Depending on how one views it, the stock price performance for the year has been a mixed bag, resulting in either an optimistic or pessimistic outlook. Until today this year the stock’s price performance recorded an increase of 98.73%. WebApr 9, 2024 · The New York Stock Exchange was closed for Good Friday. Nonfarm payrolls grew by 236,000 for the month, about in line with the Dow Jones estimate of 238,000, the Labor Department reported. The...
Ctxr analysis
Did you know?
Web2 days ago · CTXR’s beta can be found in Trading Information at the top of this page. A stock’s beta measures how closely tied its price movements have been to the … WebApr 4, 2024 · Key Expected Earnings Data Earnings Summary For their last quarter, Citius Pharmaceuticals (CTXR) reported earnings of -$0.04 per share. This reflects a breakeven earnings surprise. Look out for...
WebBased on analysts offering 12 month price targets for CTXR in the last 3 months. The average price target is $ 0.00 with a high estimate of $ 0.00 and a low estimate of $ 0.00 . WebMar 1, 2024 · Citius Pharmaceuticals, Inc. (NASDAQ: CTXR) is a Cranford, New Jersey based late-stage drug concern focused on the development of therapies that are typically reformulations of previously...
WebApr 13, 2024 · According to the data, the short interest in Citius Pharmaceuticals Inc. (CTXR) stood at 7.83% of shares outstanding as of Mar 14, 2024; the number of short shares registered in Feb 14, 2024 reached 10.97 million. The stock has risen by 98.73% since the beginning of the year, thereby showing the potential of a further growth.
WebMar 30, 2024 · Live In Play®. Updated: 30-Mar-23 08:33 ET. CTXR: Citius Pharmaceuticals advances efforts to spin off oncology asset, I/ONTAK, into a standalone public company (1.10) Co announced that Maxim Group LLC will serve as financial advisor to its wholly-owned subsidiary, Citius Acquisition Corp. Inc., in connection with the intended formation …
WebThe Citius Pharmaceuticals stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention. 1川越市WebThe current Citius Pharmaceuticals [ CTXR] share price is $1.16. The Score for CTXR is 52, which is 4% above its historic median score of 50, and infers lower risk than normal. CTXR is currently trading in the 50-60% percentile range relative to its historical Stock Score levels. 1川柳WebApr 9, 2024 · Check out our latest analysis for Delta Air Lines . NYSE:DAL Ownership Breakdown April 9th 2024 What Does The Institutional Ownership Tell Us About Delta Air Lines? Many institutions measure their performance against an index that approximates the local market. So they usually pay more attention to companies that are included in major … 1巡後の世界Web20 hours ago · Price To Cash Flow is a widely used stock evaluation measure. Find the latest Price To Cash Flow for Citius Pharmaceuticals (CTXR) 1巨潮咨询WebCitius Pharmaceuticals, Inc. Common Stock (CTXR) Nasdaq Listed 1 Earnings Date Add to Portfolio CTXR CTXR REAL TIME CTXR Real-Time Quotes 1D 5D 1M 6M YTD 1Y 5Y MAX Last Five Real-Time... 1工WebYour technical analysis summary for Citius Pharmaceuticals, Inc This gauge displays a real-time technical analysis overview for your selected timeframe. The summary of Citius … 1工日多少小时WebApr 5, 2024 · 1 equities research analysts have issued 1 year target prices for Citius Pharmaceuticals' shares. Their CTXR share price forecasts range from $6.00 to $6.00. … 1工区